Lexicon Pharmaceuticals, Inc. ( LXRX) - Stock Earnings
LXRX Upcoming earnings
Estimated EPS and revenue columns are available to paid members.
| Date | EPS (actual / est.) | Revenue low (est.) | Revenue (actual / est.) | Revenue high (est.) |
|---|---|---|---|---|
| Nov. 5, 2026, midnight | — / — | — | — / — | — |
LXRX Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q4 | -15.5 million USD | 5.5 million USD |
| 2026Q1 | -1.0 million USD | 21.1 million USD |
| 2026Q2 | -31.8 million USD | 692000 USD |
| 2026Q4 Est. | — | — |
| 2027Q1 Est. | — | — |
| 2027Q2 Est. | — | — |
LXRX Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -177.1 million USD | 1.2 million USD |
| 2024 | -200.4 million USD | 31.1 million USD |
| 2025 | -50.3 million USD | 49.8 million USD |
| 2026 Est. | — | — |
LXRX
Price: $1.52
Earnings Per Share: -0.15 USD
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 131023
Ebitda: -28.2 millionMarket Capitalization: 808.4 million